Opus Genetics, Inc. (IRD) earnings · rev $14.2M
These earnings events as JSON? API free 100/dayOpus Genetics, Inc. (IRD) is a biotechnology company listed on US.
This IRD earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported IRD revenue for 2025-12-31 was $14.2M. Net income was -$49.6M. Revenue was up 29.1% from 2024-12-31 to 2025-12-31. IRD currently screens at market cap $35.7M.
When the next IRD 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 29.1% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full IRD research stays on the stock page; the tape stays on the quote page.
IRD earnings FAQ
What are IRD's latest revenue and net income?
Latest cached Opus Genetics, Inc. (IRD) revenue for Dec 31, 2025 was $14.2M. Net income was -$49.6M. Statements: https://lician.com/financials/ird
What is IRD's latest diluted EPS?
Latest cached Opus Genetics, Inc. (IRD) diluted EPS for Dec 31, 2025 was -$0.80.
What period does the latest IRD earnings print cover?
The latest cached Opus Genetics, Inc. (IRD) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did IRD revenue change from the prior cached period?
Cached Opus Genetics, Inc. (IRD) revenue was up 29.1% from $11.0M (Dec 31, 2024) to $14.2M (Dec 31, 2025). Statements: https://lician.com/financials/ird
Where are IRD earnings listed?
Cached earnings facts for Opus Genetics, Inc. (IRD) are listed at https://lician.com/earnings/ird. Statements: https://lician.com/financials/ird
Not investment advice.